TROMBOSE VENOSA CENTRAL NÃO RELACIONADA A CATETER CENTRAL EM RECÉM-NASCIDO: RELATO DE CASO
DOI:
https://doi.org/10.36557/pbpc.v4i2.466Keywords:
Venous Thrombosis, Newborn, Pediatric ICUAbstract
Introduction: Central venous thrombosis (CVT) in neonates is an uncommon condition, typically linked to central venous catheter use. When spontaneous, its early recognition is challenging due to nonspecific clinical signs and limited reports in the literature.
Case Description: A term female neonate, born via cesarean section at 38 weeks and 3 days of gestation, weighing 3100g, with Apgar scores of 9 and 10 at 1 and 5 minutes, respectively, without need for resuscitation and had a normal initial physical exam. The mother had a prior diagnosis of type 1 diabetes mellitus, treated with insulin and metformin during pregnancy, and an obstetric history of three previous pregnancies, including two cesarean deliveries and one miscarriage. On postnatal day 1, the infant developed symmetrical upper limb myoclonic jerks during the first 48 hours of life. Cranial ultrasonography revealed hemorrhagic lesions, and brain Magnetic Resonance Imaging (MRI) demonstrated hemorrhagic venous infarction in the right anterior thalamus, with thrombosis of the right internal cerebral vein and thalamic drainage vein. Electroencephalography showed no epileptiform activity. Treatment with enoxaparin and phenobarbital was initiated, with favorable clinical progression and hospital discharge on day 10.
Discussion: This case underscores the importance of clinical suspicion and early diagnosis of neonatal CVT, even in the absence of central venous catheters, the most common risk factor. Neonatal coagulation immaturity contributes to thrombotic vulnerability, and low molecular weight heparin appears safe and effective in this population.
Conclusion: Spontaneous neonatal CVT is rare but clinically significant. Prompt recognition and appropriate management are critical to improving outcomes and minimizing neurological sequelae, even when classical risk factors are absent.
Downloads
References
Almendra M, Gonçalves CS, Casimito A, Estrada JF. Tromboembolismo venoso em idade pediátrica: um olhar de 20 anos numa unidade de cuidados intensivos pediátricos. Resid Pediatr. 2024;14(1). doi:10.25060/residpediatr-2024.v14n1-995
Bruschettini M, et al. Heparin for the prevention of intraventricular haemorrhage in preterm infants. Cochrane Database Syst Rev. 2016 May;2016(5):CD011718. doi:10.1002/14651858.CD011718.pub2
Chan AKC, Bhatt MD, O’Brien S, Garcia-Prats JA, Armsby C. Neonatal thrombosis: clinical features and diagnosis [Internet]. UpToDate; 2025 [citado 2025 Mar 1]. Disponível em: https://www.uptodate.com
Christensen R, et al. Cerebral venous sinus thrombosis in preterm infants. Stroke. 2022 Jul;53(7):2241-8. doi:10.1161/STROKEAHA.121.037621
Correa Barria DA, Díaz Olivares MA, Lara López SE, Valenzuela Aguilera MA. Trombosis en el recién nacido. Rev Pediatr Electron [Internet]. 2021 [citado 2025 Mar 1];18(1). Disponível em: https://www.revistapediatriaelectronica.cl
Gano D, Wu Y, Nordli DR Jr, Martin R, Dashe JF, Tehrani N. Neonatal encephalopathy: clinical features and diagnosis [Internet]. UpToDate; 2025 [citado 2025 Mar 1]. Disponível em: https://www.uptodate.com
Jaffray J, et al. Development of a risk model for pediatric hospital-acquired thrombosis: a report from the Children’s Hospital-Acquired Thrombosis Consortium. J Pediatr. 2021 Jan;228:252-9.e1. doi:10.1016/j.jpeds.2020.09.016
Jani S, Ariss R, Velumula P, Altinok D, Chawla S. Term infant with cerebral venous sinus thrombosis. Case Rep Pediatr. 2020;2020:8883007. doi:10.1155/2020/8883007
Lira LAS, Carneiro JDA, Duarte MCMMB. Pediatric venous thromboembolism: incidence and patient profile in a single Brazilian institution. Hematol Transfus Cell Ther. 2024 Nov;46(Suppl 5):S227-32. doi:10.1016/j.htct.2024.06.006
Robinson V, et al. Thrombosis in infants in the neonatal intensive care unit: analysis of a large national database. J Thromb Haemost. 2021 Feb;19(2):400-7. doi:10.1111/jth.15144
Romantsik O, Bruschettini M, Zappettini S, Ramenghi LA, Calevo MG. Heparin for the treatment of thrombosis in neonates. Cochrane Database Syst Rev. 2016 Nov;(11):CD012185. doi:10.1002/14651858.CD012185.pub2
Rühle F, Stoll M. Advances in predicting venous thromboembolism risk in children. Br J Haematol. 2018 Mar;180(5):654-65. doi:10.1111/bjh.15060
Sharathkumar AA, Biss T, Kulkarni K, Ahuja S, Regan M, Male C, Revel-Vilk S. Epidemiology and outcomes of clinically unsuspected venous thromboembolism in children: a systematic review. J Thromb Haemost. 2020 May;18(5):1100-12. doi:10.1111/jth.14739
Shellhaas R, Nordli DR Jr, Garcia-Prats JA, Dashe JF. Clinical features, evaluation, and diagnosis of neonatal seizures [Internet]. UpToDate; 2025 [citado 2025 Mar 1]. Disponível em: https://www.uptodate.com
Sociedade Portuguesa de Neonatologia. Consenso clínico “Trombose neonatal” [Internet]. 2023 [citado 2025 Mar 1]. Disponível em: https://www.spneonatologia.pt/wp-content/uploads/2018/05/Consenso-TVP-neonatal.pdf
Young G. How I treat pediatric venous thromboembolism. Blood. 2017 Sep 21;130(12):1402-8. doi:10.1182/blood-2017-04-742320
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Betina Armanini de Lima, Paulo André Ribeiro, Ana Clara Guimarães Justo Pereira, Eduarda de Souza Lopes

This work is licensed under a Creative Commons Attribution 4.0 International License.
Você tem o direito de:
- Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato para qualquer fim, mesmo que comercial.
- Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
- O licenciante não pode revogar estes direitos desde que você respeite os termos da licença.
De acordo com os termos seguintes:
- Atribuição — Você deve dar o crédito apropriado , prover um link para a licença e indicar se mudanças foram feitas . Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.